Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
11/17/2014 11/18/2014 11/19/2014 11/20/2014 11/21/2014 Date
2845.4(c) 2849(c) 2916(c) 2917(c) 2941(c) Last
6 019 12 143 25 823 16 680 19 942 Volume
-0.13% +0.13% +2.35% +0.03% +0.82% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
02/17Earnings Release
Surperformance© rating of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More about the company
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2014 27 240 M
EBIT 2014 5 848 M
Net income 2014 5 171 M
Finance 2014 9 417 M
Yield 2014 1,83%
Sales 2015 30 525 M
EBIT 2015 7 260 M
Net income 2015 6 301 M
Finance 2015 9 456 M
Yield 2015 1,96%
PER 2014 47,86
PER 2015 39,36
EV / Sales 2014 8,75x
EV / Sales 2015 7,81x
Capitalization 247 866 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
3d ago GLAXOSMITHKLINE PHARMACEUTICALS : Bt500 rankings: india's most valuable top-500 ..
4d ago GLAXOSMITHKLINE : Glaxo Says Positive Mekinist & Tafinlar Combination Study Publ..
11/12 GLAXOSMITHKLINE : Glaxo Seeking Additional Indication For Eltrombopag In EMA Sub..
11/10 GLAXOSMITHKLINE PHARMACEUTICALS : Pharma Q3 net up 27% at Rs 128.67 cr
11/07 GLAXOSMITHKLINE PHARMACEUTICALS : GSK PHARMA Q3 NET UP 27% AT Rs129 CRORE
11/05 GLAXOSMITHKLINE PHARMACEUTICALS : Taurus Securities Limited Market Roundup
11/05 GLAXOSMITHKLINE : Glaxo Submits European, US Filings For Mepolizumab
10/24 Five Prime Therapeutics Expands Collaboration With Glaxo
10/23 GLAXOSMITHKLINE : DIRECTOR DEALINGS: Glaxo Chief Executive Exercises Options, Se..
10/23 GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
10/22 GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
10/22 GLAXOSMITHKLINE PHARMACEUTICALS : Law firms from US boost their HK staffs
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF